Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Inhibition of NADPH cytochrome P450 reductase by the model sulfur mustard vesicant 2-chloroethyl ethyl sulfide is associated with increased production of reactive oxygen species.

Gray JP, Mishin V, Heck DE, Laskin DL, Laskin JD.

Toxicol Appl Pharmacol. 2010 Sep 1;247(2):76-82. doi: 10.1016/j.taap.2010.05.015. Epub 2010 Jun 2.

2.

Efficacy of glutathione in ameliorating sulfur mustard analog-induced toxicity in cultured skin epidermal cells and in SKH-1 mouse skin in vivo.

Tewari-Singh N, Agarwal C, Huang J, Day BJ, White CW, Agarwal R.

J Pharmacol Exp Ther. 2011 Feb;336(2):450-9. doi: 10.1124/jpet.110.173708. Epub 2010 Oct 25. Review.

3.

Mustard vesicant-induced lung injury: Advances in therapy.

Weinberger B, Malaviya R, Sunil VR, Venosa A, Heck DE, Laskin JD, Laskin DL.

Toxicol Appl Pharmacol. 2016 Aug 15;305:1-11. doi: 10.1016/j.taap.2016.05.014. Epub 2016 May 19. Review.

4.

Mustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure.

Tewari-Singh N, Agarwal R.

Ann N Y Acad Sci. 2016 Jun;1374(1):184-92. doi: 10.1111/nyas.13099. Epub 2016 Jun 21. Review.

5.

Macrophages and inflammatory mediators in pulmonary injury induced by mustard vesicants.

Malaviya R, Sunil VR, Venosa A, Vayas KN, Businaro R, Heck DE, Laskin JD, Laskin DL.

Ann N Y Acad Sci. 2016 Jun;1374(1):168-75. doi: 10.1111/nyas.13123. Epub 2016 Jun 28. Review.

Supplemental Content

Support Center